De typografische vormgeving van informatie over medicijnen: een diagnose in historisch perspectief
Effective, appropriate and safe usage of medicines is only possible if they come with clear instructions, recommendations, descriptions and warnings. Clear information about medication does not only benefit seniors, who consume the greatest amount of prescription drugs, but also users in other age groups, such as children and their caretakers. The typographic design of this information plays a crucial role, but is, unfortunately, rarely optimized to suit different reading audiences’ needs. Still commonly seen are poorly readable patient information leaflets with ‘small font on translucent paper’ stowed in generic paper packaging. The lacking typographic design can mostly be explained by historically determined legal and economical requirements. European legislation, for example, demands a conservative approach, mainly to reach standardization. The pharmaceutical industry is hesitant, out of fear that the changes will come at high costs. Both explanations make it difficult to meet the professional principles of typographic designers striving for optimized transfer of information. This is the crux of the matter, the reason why convenient, readable medication information leaflets are in short supply. This article examines two underlying questions. When it comes to drug information, there have been three pivotal changes in society: patients are more actively involved in their own treatment; patients’ cultural backgrounds are more diverse; and there is a growing demand for digital information. The first question is: why have these changes in society barely made an impact on the typographic design of information leaflets? The second question is: why is existing professional knowledge hardly utilized, such as insights into readability, or the practical knowledge and experience developed for the pharmaceutical industry by prominent representatives of the Swiss Style (=‘International Typographic Style’)?
|Keywords||informatie voor patiënten, ontwerpproces, professionele kennis, EMA QRD template, leesbaarheid|
|Publisher||Netherlands Institute for Sound and Vision|
|Journal||Tijdschrift voor Mediageschiedenis|
|Rights||Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).|
|Note||TMG Journal for Media History; Vol 19, No 2 (2016): Typografie in mediahistorisch perspectief; 1-11|
van der Waarde, Karel. (2016). De typografische vormgeving van informatie over medicijnen: een diagnose in historisch perspectief. Tijdschrift voor Mediageschiedenis, 19(2), 1–11. doi:10.18146/2213-7653.2016.267